Vicus Capital lifted its stake in Colgate-Palmolive (NYSE:CL) by 14.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 138,107 shares of the company’s stock after buying an additional 17,240 shares during the period. Colgate-Palmolive makes up approximately 1.9% of Vicus Capital’s holdings, making the stock its 9th largest holding. Vicus Capital’s holdings in Colgate-Palmolive were worth $10,061,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. OLD Second National Bank of Aurora bought a new stake in Colgate-Palmolive during the 2nd quarter valued at approximately $109,000. Krilogy Financial LLC boosted its position in Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after acquiring an additional 289 shares in the last quarter. Harbour Capital Advisors LLC bought a new stake in Colgate-Palmolive during the 1st quarter valued at approximately $121,000. Hanson & Doremus Investment Management boosted its position in Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares in the last quarter. Finally, Captrust Financial Advisors purchased a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $122,000. Hedge funds and other institutional investors own 72.83% of the company’s stock.
Colgate-Palmolive (NYSE CL) traded up $0.07 on Friday, hitting $74.62. 2,338,181 shares of the company’s stock traded hands, compared to its average volume of 3,030,000. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27. The company has a market cap of $65,520.00, a P/E ratio of 28.81, a PEG ratio of 3.15 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the firm earned $0.73 EPS. The business’s revenue was up 2.8% on a year-over-year basis. analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
CL has been the subject of several recent research reports. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday, September 20th. Morgan Stanley upgraded shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $75.00 to $84.00 in a report on Monday, September 25th. Jefferies Group restated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, September 28th. Royal Bank of Canada reiterated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Finally, SunTrust Banks upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and boosted their target price for the company from $65.00 to $85.00 in a research note on Wednesday, October 11th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $76.51.
In other news, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total transaction of $730,700.00. Following the sale, the insider now directly owns 60,528 shares in the company, valued at approximately $4,422,780.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the sale, the director now owns 36,268 shares in the company, valued at $2,557,619.36. The disclosure for this sale can be found here. Insiders have sold a total of 181,950 shares of company stock valued at $13,237,385 in the last three months. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.